IL-1β-induced activation of p38 promotes metastasis in gastric adenocarcinoma via upregulation of AP-1/c-fos, MMP2 and MMP9

Molecular Cancer

Volumn 13, Issue 1, 2014, Pages

  Huang, Qiaojia ^a   Lan, Fenghua ^a   Wang, Xiaoting ^a   Yu, Yinghao ^a   Ouyang, Xuenong ^a   Zheng, Feng ^a   Han, Junyong ^a   Lin, Youdong ^a   Xie, Yanchuan ^a   Xie, Feilai ^a   Liu, Wei ^a   Yang, Xiaoli ^a   Wang, Han ^a   Dong, Lihong ^a   Wang, Lie ^a   Tan, Jianming ^a  

^a FUZHOU GENERAL HOSPITAL   (China)

Author keywords

AP 1; Gastric adenocarcinoma; IL 1 ; Metastasis; MMP2 and MMP9; p38

Indexed keywords

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANIMALS; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL MOVEMENT; ENZYME ACTIVATION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-1BETA; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MICE; MICE, NUDE; MICROSCOPY, CONFOCAL; MIDDLE AGED; NEOPLASM INVASIVENESS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTO-ONCOGENE PROTEINS C-FOS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STOMACH NEOPLASMS; TRANSCRIPTION FACTOR AP-1; TRANSFECTION; UP-REGULATION;

EID: 84893173731     PISSN: None     EISSN: 14764598     Source Type: Journal    
DOI: 10.1186/1476-4598-13-18     Document Type: Article

References (37)

1. Qin LX. Inflammatory immune responses in tumor microenvironment and metastasis of hepatocellular carcinoma. Cancer Microenviron 2012, 5:203-209. 10.1007/s12307-012-0111-1, 3460054, 22678823.
2. Leonardi GC, Candido S, Cervello M, Nicolosi D, Raiti F, Travali S, Spandidos DA, Libra M. The tumor microenvironment in hepatocellular carcinoma. Int J Oncol 2012, 40:1733-1747.
3. Soria G, Ofri-Shahak M, Haas I, Yaal-Hahoshen N, Leider-Trejo L, Leibovich-Rivkin T, Weitzenfeld P, Meshel T, Shabtai E, Gutman M. Ben-Baruch: a inflammatory mediators in breast cancer: coordinated expression of TNFα & IL-1β with CCL2 & CCL5 and effects on epithelial-to-mesenchymal transition. BMC Cancer 2011, 11:130. 10.1186/1471-2407-11-130, 3095565, 21486440.
4. Serelli-Lee V, Ling KL, Ho C, Yeong LH, Lim GK, Ho B, Wong SB. Persistent helicobacter pylori specific Th17 responses in patients with past H. pylori infection are associated with elevated gastric mucosal IL-1β. PLos One 2012, 7:e39199. 10.1371/journal.pone.0039199, 3382622, 22761739.
5. Munshi A, Ramesh R. Mitogen-activated protein kinases and their role in radiation response. Genes Cancer 2013, 4:401-408. 10.1177/1947601913485414, 3863336, 24349638.
6. Yeung YT, Bryce NS, Adams S, Braidy N, Konayagi M, McDonald KL, Teo C, Guillemin GJ, Grewal T, Munoz L. p38 MAPK inhibitors attenuate pro-inflammatory cytokine production and the invasiveness of human U251 glioblastoma cells. J Neurooncol 2012, 109:35-44. 10.1007/s11060-012-0875-7, 22528800.
7. Meng F, Zhang H, Liu G, Kreike B, Chen W, Sethi S, Miller FR, Wu G. p38γ mitogen-activated protein kinase contributes to oncogenic properties maintenance and resistance to poly (ADP-ribose)-polymerase-1 inhibition in breast cancer. Neoplasia 2011, 13:472-482. 3084624, 21532888.
8. Goedert M, Cuenda A, Craxton M, Jakes R, Cohen P. Activation of the novel stress-activated protein kinase SAPK4 by cytokines and cellular stresses is mediated by SKK3 (MKK6); comparison of its substrate specificity with that of other SAP kinases. EMBO J 1997, 16:3563-3571. 10.1093/emboj/16.12.3563, 1169981, 9218798.
9. Risco A, Cuenda A. New insights into the p38γ and p38δ MAPK pathways. J Signal Transduct 2012, 2012:520289. 3235882, 22175015.
10. Cuadrado A, Nebreda AR. Mechanisms and functions of p38 MAPK signaling. Biochem J 2010, 429:403-417. 10.1042/BJ20100323, 20626350.
11. Huang Q, Yang J, Lin Y, Walker C, Cheng J, Liu ZG, Su B. Differential regulation of interleukin 1 receptor and Toll-like receptor signaling by MEKK3. Nat Imm 2004, 5:98-103.
12. Kim K, Duramad O, Qin XF, Su B. MEKK3 is essential for lipopolysaccharide-induced interleukin-6 and granulocyte-macrophage colony-stimulating factor production in macrophages. Immunology 2007, 120:242-250. 10.1111/j.1365-2567.2006.02495.x, 2265862, 17116170.
13. Khair M, Bourhim M, Barré L, Li D, Netter P, Magdalou J, Fournel-Gigleux S, Ouzzine M. Regulation of xylosyltransferase I gene expression by interleukin 1β in human primary chondrocyte cells: mechanism and impact on proteoglycan synthesis. J Biol Chem 2013, 288:1774-1784. 10.1074/jbc.M112.419887, 3548487, 23223231.
14. Chen J, Gallo KA. MLK3 regulates paxillin phosphorylation in chemokine-mediated breast cancer cell migration and invasion to drive metastasis. Cancer Res 2012, 72:4130-4140. 10.1158/0008-5472.CAN-12-0655, 22700880.
15. Kwon CH, Moon HJ, Park HJ, Choi JH, Park do Y. S100A8 and S100A9 promotes invasion and migration through p38 mitogen-activated protein kinase-dependent NF-κB activation in gastric cancer cells. Mol Cells 2013, 35:226-234. 10.1007/s10059-013-2269-x, 23456298.
16. Van Tubergen EA, Banerjee R, Liu M, Vander Broek R, Light E, Kuo S, Feinberg SE, Willis AL, Wolf G, Carey T, Bradford C, Prince M, Worden FP, Kirkwood KL, D'Silva NJ. Inactivation or loss of TTP promotes invasion in head and neck cancer via transcript stabilization and secretion of MMP9, MMP2, and IL-6. Clin Cancer Res 2013, 19:1169-1179. 10.1158/1078-0432.CCR-12-2927, 23349315.
17. Lemieux E, Bergeron S, Durand V, Asselin C, Saucier C, Rivard N. Constitutively active MEK1 is sufficient to induce epithelial-to-mesenchymal transition in intestinal epithelial cells and to promote tumor invasion and metastasis. Int J Cancer 2009, 125:1575-1586. 10.1002/ijc.24485, 19462441.
18. Lee JG, Heur M. Interleukin-1β enhances cell migration through AP-1 and NF-κB pathway-dependent FGF2 expression in human corneal endothelial cells. Biol Cell 2013, 105:175-189. 10.1111/boc.201200077, 23331079.
19. Luo Y, Liang F, Zhang ZY. PRL1 promotes cell migration and invasion by increasing MMP2 and MMP9 expression through Src and ERK1/2 pathways. Biochemistry 2009, 48:1838-1846. 10.1021/bi8020789, 2765538, 19199380.
20. Bian J, Sun Y. Transcriptional activation by p53 of the human type IV collagenase (gelatinase a or matrix metalloproteinase 2) promoter. Mol Cell Biol 1997, 17:6330-6338. 232484, 9343394.
21. Mehta PB, Jenkins BL, McCarthy L, Thilak L, Robson CN, Neal DE, Leung HY. MEK5 overexpression is associated with metastatic prostate cancer, and stimulates proliferation, MMP-9 expression and invasion. Oncogene 2003, 22:1381-1389. 10.1038/sj.onc.1206154, 12618764.
22. Na HK, Kim EH, Choi MA, Park JM, Kim DH, Surh YJ. Diallyl trisulfide induces apoptosis in human breast cancer cells through ROS-mediated activation of JNK and AP-1. Biochem Pharmacol 2012, 84:1241-1250. 10.1016/j.bcp.2012.08.024, 22981381.
23. Moore HM, Gonzalez ME, Toy KA, Cimino-Mathews A, Argani P, Kleer CG. EZH2 inhibition decreases p38 signaling and suppresses breast cancer motility and metastasis. Breast Cancer Res Treat 2013, 138:741-752. 10.1007/s10549-013-2498-x, 23539298.
24. Mao L, Yuan L, Slakey LM, Jones FE, Burow ME, Hill SM. Inhibition of breast cancer cell invasion by melatonin is mediated through regulation of the p38 mitogen-activated protein kinase signaling pathway. Breast Cancer Res 2010, 12:R107. 10.1186/bcr2794, 3046452, 21167057.
25. Park SY, Jeong KJ, Panupinthu N, Yu S, Lee J, Han JW, Kim JM, Lee JS, Kang J, Park CG, Mills GB, Lee HY. Lysophosphatidic acid augments human hepatocellular carcinoma cell invasion through LPA1 receptor and MMP-9 expression. Oncogene 2011, 30:1351-1359. 10.1038/onc.2010.517, 21102517.
26. Hsieh YH, Wu TT, Huang CY, Hsieh YS, Hwang JM, Liu JY. p38 mitogen-activated protein kinase pathway is involved in protein kinase calpha-regulated invasion in human hepatocellular carcinoma cells. Cancer Res 2007, 67:4320-4327. 10.1158/0008-5472.CAN-06-2486, 17483345.
27. Yan Q, Bach DQ, Gatla N, Sun P, Liu JW, Lu JY, Paller AS, Wang XQ. Deacetylated GM3 promotes uPAR-associated membrane molecular complex to activate p38 MAPK in metastatic melanoma. Mol Cancer Re. 2013, 11:665-675.
28. Hanna SC, Krishnan B, Bailey ST, Moschos SJ, Kuan PF, Shimamura T, Osborne LD, Siegel MB, Duncan LM, O'Brien ET, Superfine R, Miller CR, Simon MC, Wong KK, Kim WY. HIF1α and HIF2α independently activate SRC to promote melanoma metastases. J Clin Invest 2013, 123:2078-2093. 10.1172/JCI66715, 3635738, 23563312.
29. Lee SJ, Kim WJ, Moon SK. Role of the p38 MAPK signaling pathway in mediating interleukin-28A-induced migration of UMUC-3 cells. Int J Mol Med 2012, 30:945-952.
30. Braun L, Brenier-Pinchart MP, Yogavel M, Curt-Varesano A, Curt-Bertini RL, Hussain T, Kieffer-Jaquinod S, Coute Y, Pelloux H, Tardieux I, Sharma A, Belrhali H, Bougdour A, Hakimi MA. A Toxoplasma dense granule protein, GRA24, modulates the early immune response to infection by promoting a direct and sustained host p38 MAPK activation. J Exp Med 2013, 210:2071-2086. 10.1084/jem.20130103, 24043761.
31. Verma G, Bhatia H, Datta M. Gene expression profiling and pathway analysis identify the integrin signaling pathway to be altered by IL-1β in human pancreatic cancer cells: role of JNK. Cancer Lett 2012, 320:86-95. 10.1016/j.canlet.2012.01.036, 22313544.
32. Huang QJ, Huang QL, Chen WN, Wang L, Lin WS, Lin JY, Lin X. Identification of transgelin as a potential novel biomarker for gastric adenocarcinoma based on proteomics technology. J Cancer Res Clin Oncol 2008, 134:1219-1227. 10.1007/s00432-008-0398-y, 18446369.
33. Huang Q, Lan F, Zheng Z, Xie F, Han J, Dong L, Xie Y, Zheng F. Akt2 suppresses GAPDH mediated-apoptosis in ovarian cancer cells via phosphorylating GAPDH at threonine 237 and decreasing its nuclear translocation. J Biol Chem 2011, 286:42211-42220. 10.1074/jbc.M111.296905, 3234938, 21979951.
34. Ju XZ, Yang JM, Zhou XY, Li ZT, Wu XH. Emmprin expression as a prognostic factor in radiotherapy. Clin Cancer Res 2008, 12:494-501.
35. Sumida T, Itahana Y, Hamakawa H, Desprez1 PY. Reduction of human metastatic breast cancer cell aggressiveness on introduction of either form A or B of the progesterone receptor and then treatment with progestins. Cancer Res 2004, 64:7886-7892. 10.1158/0008-5472.CAN-04-1155, 15520195.
36. Ma L, Fenghua Lan F, Zheng Z, Xie F, Wang L, Liu W, Han J, Zheng F, Xie Y, Huang Q. Epidermal growth factor (EGF) and interleukin (IL)-1β synergistically promote ERK1/2-mediated invasive breast ductal cancer cell migration and invasion. Mol Cancer 2012, 11:79. 10.1186/1476-4598-11-79, 3537707, 23083134.
37. Yan M, Xu Q, Zhang P, Zhou XJ, Zhang ZY, Chen WT. Correlation of NF-kappaB signal pathway with tumor metastasis of human head and neck squamous cell carcinoma. BMC Cancer 2010, 10:437. 10.1186/1471-2407-10-437, 2931490, 20716363.